Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
about
Specific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and strokePET and MR imaging of neuroinflammation in hepatic encephalopathy.PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.Could (18) F-DPA-714 PET imaging be interesting to use in the early post-stroke period?[(18)F]DPA-714 PET imaging of AMD3100 treatment in a mouse model of stroke.Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.Molecular imaging of microglial activation in amyotrophic lateral sclerosis.Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients.Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice.Current imaging strategies in rheumatoid arthritisEvaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation.Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11C]CB184, in healthy human volunteers.Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomographyMapping neuroinflammation in frontotemporal dementia with molecular PET imaging.Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats.Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation.A Facile Radiolabeling of [18F]FDPA via Spirocyclic Iodonium Ylides: Preliminary PET Imaging Studies in Preclinical Models of NeuroinflammationRecent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging in Neurological Diseases.Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.[18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain.Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging.Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates.Synthesis and evaluation of new (18)F-labelled acetamidobenzoxazolone-based radioligands for imaging of the translocator protein (18 kDa, TSPO) in the brain.Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT.Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.[18F]DPA-C5yne, a novel fluorine-18-labelled analogue of DPA-714: radiosynthesis and preliminary evaluation as a radiotracer for imaging neuroinflammation with PET.Characterization of a novel acetamidobenzoxazolone-based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain.Inflammatory projections after focal brain injury trigger neuronal network disruption: An F-DPA714 PET study in miceAssessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)
P2860
Q28535065-3738451A-8BAD-4D83-BC42-A5EF9973FEAEQ30878855-A04523C5-FDA1-43D1-A8AE-C667F04B0A81Q33748021-02E53086-D234-40FC-BE8C-CF563B19290EQ33830420-CD236BCB-395B-4A42-8426-539F0B5EDE9BQ34293578-F9553F0C-B6A2-49ED-B658-7B88A5A18646Q34315675-E7E56722-2066-46EC-9899-E84A7066460FQ34541448-712A4BBD-1737-43C3-AB57-9E04BB01F7A8Q35213599-2C611551-3455-4BDD-B55B-FEF11925172BQ35572798-5EE83DAF-0626-401E-BCAF-DD84AA9FE30AQ36215957-28FF4C20-0C40-4C17-AF62-C93C9EE6C28FQ36337258-042E6341-F798-43FD-B7A7-0438C100EC66Q36488310-8450E360-C259-4A6F-A7AD-7E5625D11144Q37380723-1DCCFF38-5FD1-4F1F-BA98-CFEE5B8D131CQ37718960-DB26C665-2B50-437B-AF86-BA10789F30C6Q38244707-A4011781-0D38-4E7B-8F7A-AF771E0E7644Q38506602-9F8AD29A-5AC3-45FF-908D-724AE6DFD59EQ38810544-1B752A4C-6052-400D-B84B-F99023832BD6Q39033807-C559B8DE-3845-429D-9852-4E8BEDBAAA3AQ39535676-1D4A71DA-8618-4D66-AEFB-54AB086E17EBQ39666235-C737D0CC-F163-4BB8-931C-EFE5495217A8Q40952031-2476562B-8955-4A2B-85E6-85D4BB03969FQ41556036-5B4BFFFF-E976-42F0-B963-90AC840AE480Q47291761-DDCB79F7-8883-4D65-8E18-1E5AF611BA6BQ47979574-48ED9EE9-0436-433D-9533-1F80F871B738Q48419598-E3F3F691-0F1A-4921-9308-492E676A3730Q48433741-354870B0-C22E-414E-A47C-B275B43CFF81Q48472695-36D5F414-20B8-4AB6-972B-226CE2E9955EQ48477604-CCE9BEE4-55C8-4B83-801E-FDD628F01332Q48946777-1FADF66A-FA3A-430C-8972-E49A3BFA2A5CQ52150208-E32E5991-133E-47CC-994A-056B29D9AFE6Q53068160-5E977F0F-46EE-4906-A26C-538D8F947E30Q53081115-5E0446B2-1CDD-49D3-A7BA-5D50BA72DCE7Q57488901-3FDDF3D9-9A26-4F6C-B41D-7AF2B118C672Q57700286-E1A28F28-4B3C-40CE-88F3-F00EE7B89EF6
P2860
Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Initial evaluation in healthy ...... omarker for neuroinflammation.
@en
Initial evaluation in healthy ...... omarker for neuroinflammation.
@nl
type
label
Initial evaluation in healthy ...... omarker for neuroinflammation.
@en
Initial evaluation in healthy ...... omarker for neuroinflammation.
@nl
prefLabel
Initial evaluation in healthy ...... omarker for neuroinflammation.
@en
Initial evaluation in healthy ...... omarker for neuroinflammation.
@nl
P2093
P50
P1476
Initial evaluation in healthy ...... omarker for neuroinflammation.
@en
P2093
Aaron Reynolds
Jean-Louis Baulieu
Maria-João Ribeiro
Michael G Stabin
Michael Kassiou
Serge Maia
Yann Venel
P304
P356
10.1016/J.NUCMEDBIO.2011.10.012
P577
2011-12-14T00:00:00Z